Update on Fund Management arrangements

Intl. Biotechnology Trust PLC

20 November 2023

 

20 November 2023

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

Update on Fund Management arrangements and related services

Further to the Company's previous announcements, the Board is pleased to report that with effect from 20 November 2023:

·      Schroder Unit Trusts Limited ("SUTL") has been appointed as the Company's Fund Manager and Alternative Investment Fund Manager ("AIFM").

·      Ailsa Craig and Marek Poszepczynski have joined Schroder Investment Management Limited ("SIML", a sister company to SUTL) from SV Health Partners LLP and will continue as the Company's portfolio managers.

·      The Depositary agreement with Northern Trust Company has been terminated and the Company's new Depositary will be HSBC Bank plc.

·      The Company's website is www.schroders.com/IBT.

·      SIML has been appointed as Company Secretary and can be contacted at [e-mail].

·      The registered office address of the Company is set to change to 1 London Wall Place, London EC2Y 5AU.

For further information, please contact:

Fund Manager - SUTL

Augustine Chipungu      [phone]

Corporate Broker - Deutsche Numis

Nathan Brown                [phone] / [phone]

Financial PR - KL Communications

Charles Gorman            [phone] / [phone]

LEI: 213800N1QUJ744P76D11

 

END